Altered growth hormone (GH) secretion in women gaining weight during hormone replacement therapy (HRT)

Maturitas

Volumn 25, Issue 1, 1996, Pages 29-34

  Hartmann, Beda W ^a   Kirchengast, Sylvia ^b   Albrecht, Alexander E ^a   Söregi, Gabor ^a   Huber, Johannes C ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Growth hormone; Growth hormone relasing hormone; Hormone replacement therapy; Insulin like growth factor I; Weight gain

Indexed keywords

ESTRADIOL VALERATE; ESTROGEN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOMEDIN C;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; WEIGHT GAIN;

EID: 0030217940     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(96)01035-3     Document Type: Article

References (23)

1. [1] Frantz AG, Rabkin MT. Effects of estrogen and sex difference on secretion of human growth hormone. J Clin Endocrinol Metab. 1965; 25: 1470-1480.
2. [2] Unger RH, Eisentraut AM, Madison LL, Sipperstein MD. Fasting levels of growth hormone in men and women. Nature 1965; 205: 804-805.
3. [3] Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R., Rogol AD, Kaiser DL, Thorner MO. Effects of sex and age on the 24-h profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987; 64: 51-58.
4. [4] Merimee TJ, Rabinowitz D, Fineberg SE. Arginin initiated release of human growth hormone. N Eng J Med 1969; 26: 1434-1438.
5. [5] Bennet AE, Wahner HW, Riggs BL, Hintz RL. Insulin like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab 1984; 59: 701-704.
6. [6] Bacon GE, Lowery GH, Knoller M. Comparison of arginin infusion and diethylsilbestrol as a means of provoking growth hormone secretion. J Pediatr 1969; 75: 385-390.
7. [7] Fröhlander N, Von Schoultz B. Growth hormone and somatomedin C during postmenopausal replacement therapy with estrogen alone and in combination with an antiestrogen. Maturitas 1988; 9: 297-302.
8. [8] Dawson-Huges B, Stern D, Goldmann J, Reichlin S. Regulation of growth hormone and somatomedin C secretion in postmenopausal women: Effect of physiological estrogen replacement. J Clin Endocrinol Metab 1986; 63: 424-432.
9. [9] Wilson DM, Dotson RJ, Neely EK, Cohen P, Hintz RL, Rosenfeld RG. Effects of estrogen on growth hormone following clonidine stimulation. AJDC 1993; 147: 63-65.
10. [10] Bellantoni MF, Harman SM, Cho DE, Blackman MR. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor -I in postmenopausal women of different ages. J Clin Endocrinol Metab. 1991; 72: 172-178.
11. [11] Caudron J, Hendrickx B. Comparison of two equine estrogen-dydrogesterone regimens in the climacteric. Maturitas 1988; 10: 133-141.
12. [12] Rudmann D, Kutner MH, Rogers M, Lubin MF, Fleming GA, Bain RP. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 1981; 67: 1361-1366.
13. [13] Othmer E, Levine WR, Malarkey WB, Corvalan JC, Hayden-Otto MP, Fishman PM, Daughaday WH. Body built and sleep related growth hormone secretion. Horm Res 1974; 5: 156-162.
14. [14] Gelato MC, Pescovitz OH, Cassorla F, Loriaux DL, Merriam GR. Dose-response relationships for the effects of growth hormone-releasing factor (1-44)-NH2 in young adult men and women. J Clin Endocrinol Metab. 1984; 59: 197-201.
15. [15] Utian WH. Effect of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight. Maturitas 1978; 1: 3-8.
16. [16] Ho KKY, Weissberger AJ. Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res 1992; 7: 821-827.
17. [17] Genazzani AD, Petraglia F, Volpogni C, Gastaldi M, Pianazzi F, Montanini V, Genazzani A. Modulatory role of estrogens and progestins on growth hormone episodic release with hypothalamic amenorrhea. Fertil Steril 1993; 60: 465-470.
18. [18] Williams ST, Berelowwitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA. Impaired growth hormone responses to growth hormone releasing factor in obesity. N Eng J Med 1984; 311: 1403-1407.
19. [19] Kopelman PG, Nookan K. Growth hormone response to low dose intravenous injections of growth hormone releasing factor in obese and normal weight women. Clin Endocrinol 1986; 24: 157-164.
20. [20] Guler HP, Zapf J, Scheiwiller E, Froesch ER. Recombinant human insulin like growth factor 1 stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988; 85: 4889-4893.
21. [21] Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL. Somatomedin-C mediates growth hormone negative feed back by effects on both the hypothalamus and the pituitary. Science 1981; 2: 212-220.
22. [22] Abe H, Molitch M, Van Wyk J, Underwood LE. Human growth hormone and somatomedin C supress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology 1983; 113: 1319-1324.
23. [23] Fernandez G, Sanchez-Franco F, De-Los-Frailes MT, Tolon RM, Lorenzo MJ, Lopez J, Cacicedo L. Regulation of somatostatin and growth hormone-releasing factor by gonadal steroids in fetal rat hypothalamic cells in culture. Regul Pept 1992; 42: 135-144.